"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 17 | 3 | 20 |
1996 | 14 | 6 | 20 |
1997 | 15 | 9 | 24 |
1998 | 14 | 3 | 17 |
1999 | 12 | 2 | 14 |
2000 | 17 | 5 | 22 |
2001 | 21 | 5 | 26 |
2002 | 26 | 10 | 36 |
2003 | 35 | 11 | 46 |
2004 | 47 | 14 | 61 |
2005 | 34 | 12 | 46 |
2006 | 37 | 11 | 48 |
2007 | 52 | 14 | 66 |
2008 | 49 | 15 | 64 |
2009 | 43 | 11 | 54 |
2010 | 49 | 6 | 55 |
2011 | 59 | 14 | 73 |
2012 | 69 | 9 | 78 |
2013 | 65 | 16 | 81 |
2014 | 89 | 17 | 106 |
2015 | 111 | 9 | 120 |
2016 | 79 | 23 | 102 |
2017 | 94 | 12 | 106 |
2018 | 92 | 9 | 101 |
2019 | 108 | 16 | 124 |
2020 | 138 | 12 | 150 |
2021 | 134 | 7 | 141 |
2022 | 127 | 0 | 127 |
2023 | 122 | 3 | 125 |
2024 | 72 | 29 | 101 |
2025 | 31 | 1 | 32 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
YTHDFs as radiotherapy checkpoints in tumor immunity. J Exp Med. 2025 Aug 04; 222(8).
-
Estimating Cancer Penetrance in Carriers of BRCA2 Pathogenic Variants Using Cancer-Specific Polygenic Scores. Cancer Med. 2025 Jun; 14(11):e70990.
-
Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2025 May 30; 13(5).
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference. Oncoimmunology. 2025 Dec; 14(1):2507856.
-
Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2025 May 15; 31(10):1831-1840.
-
Bispecific antibody targeting shared indel-derived neoantigen of APC. Front Immunol. 2025; 16:1574958.
-
Identification of shared neoantigens derived from frameshift mutations in the APC gene. Front Immunol. 2025; 16:1574955.
-
A randomized controlled trial adding behavioral counseling to supervised physical activity in people living with and beyond cancer (BOOST-UP-): a study protocol for a live remotely-delivered behavior change intervention. BMC Cancer. 2025 May 09; 25(1):847.
-
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire. J Immunother Cancer. 2025 May 02; 13(5).
-
Childbirth after cancer among 42 896 male adolescents and young adults: a population-based study. J Natl Cancer Inst. 2025 May 01; 117(5):1008-1017.